Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-29
1999-12-14
Mach, D. Margaret M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514345, 514351, 514352, 514354, 514357, 546290, 546304, 546314, 546326, 546329, 546339, A61K 31535, C07D21172, C07D21178, C07D21170
Patent
active
060018437
ABSTRACT:
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5284955 (1994-02-01), Strong
patent: 5438033 (1995-08-01), Drumm
patent: 5480568 (1996-01-01), Pawloski
patent: 5861419 (1999-01-01), Dube
Dube Daniel
Fortin Rejean
Friesen Richard
Gauthier Jacques Yves
Wang Zhaoyin
Billups Richard C.
M. Mach D. Margaret
Merck & Co. , Inc.
Panzer Curtis C.
Rose David L.
LandOfFree
Substituted pyridines as selective cyclooxygenase-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyridines as selective cyclooxygenase-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridines as selective cyclooxygenase-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863692